23ME610 is under clinical development by 23andMe Holding and currently in Phase II for Metastatic Renal Cell Carcinoma.
ART Births Linked to Slightly Higher Risk of Congenital Anomalies in Kids
Kids conceived using assisted reproductive technology (ART) had slightly higher risks of congenital anomalies, particularly genitourinary abnormalities, according to an Australian population-based cohort study. In